| Sl.No. | Date | Title | Learning Objectives | Expert |
|---|---|---|---|---|
| Introduction to NICPR-ECHO’s online Cancer Screening course (2:30 to 3:00 pm) Introduction to Cancer Screening and the role of medical officers in the nations’ cancer screening program | 1. Orientation (2:30 to 3:00 pm) 2. Burden of cancer in India: Prevalence, incidence and mortality of cancer 3. Causes of cancer 4. Risk factors of cancer 5. What is screening? Types of screening 6. Risks and benefits of screening 7. Introdcution to cancer screening in India |
Team NICPR-ECHO/ Dr. Kavitha Dhanasekaran, Sci-D, NICPR, New Delhi |
||
| Methods of cervical cancer Screening and their advantage and disadvantages, Cervical Cancer Screening Guidelines in India and the rationale behind it (age, frequency, when to start, when to stop etc.) | 1. Burden and natural history of cervical cancer 2. Causes, risk factors, signs and symptoms of cervical cancer 3. Anatomy & physiology of transformation zone and squamous columnar junction 4. Screening tests and their pros and cons 5. When to begin screening? For whom? 6. Optimal screening intervals 7. When to stop screening? 8. Impact of HPV vaccination on future screening 9. Operational Guidelines of MoHFW, India for cervical cancer screening |
Dr. Roopa Hariprasad, Scientist ‘E’, NICPR, Noida | ||
| Visual Inspection with Acetic Acid (VIA) & its Evaluation | 1. Brief Anatomy & Physiology of transformation Zone 2. Principle of VIA 3. Brief Step-by-step procedure of VIA with video, including the preparation of 5% acetic acid 4. Interpretations of VIA in brief 5. Briefly discuss the advantages and limitations of VIA |
Dr. Kavitha Dhansekaran, Scientist ‘D’, NICPR, Noida | ||
| Treatment of CIN and Screen Positives | 1. Types of ablative therapies (cryo & thermocoagulation,inluding videos) 2. Eligibility 3. Contraindications 4. Complications 5. Follow up 6. Types of excisional methods 7. Eligibility criteria for treatment with excisional methods 8. Follow up |
Dr. Roopa Hariprasad Scientist ‘E’, NICPR, Noida | ||
| Case Scenarios in Cervical Cancer Screening and Management | Various cases pertaining to precancerous and cancerous cervical lesions will be discussed here. (VIA +ve, VIA -ve, Screen-and-treat cases) | Dr. Roopa Hariprasad/ Dr. Kavitha Dhanasekaran | ||
| Introduction to Breast Cancer Screening, SBA & CBE | 1. Burden of breast cancer 2. Causes of breast cancer 3. Risk factors 4. Symptoms and signs of breast cancer 5. Screening methods 6. Operational guidelines of MoHFW, India for breast cancer screening 7. Role of follow up and referral in reducing the burden of cancer |
Dr. Chitresh Kumar, Asst. Prof., Sugical Oncology, National Cancer Institute AIIMS, Jhajjar | ||
| Monday, Aug 12, 2019 | Holiday (Bakrid) | |||
| Triple Assessment for Breast Cancer Screening | 1. Types of diagnostic modalities available for breast cancer screening (triple assessment) 2. Ultrasound: eligibility, advantages and limitations 3. Mammography: eligibility, advantages and limitations 4. MRI: eligibility, advantages and limitations 5. FNAC/ Biopsy |
Dr. Dhritiman Maitra, Dept of Surgery, AIIMS, New Delhi | ||
| Case scenarios pertaining to breast cancer screening | Various cases pertaining to premalignant and malignant breast lesions will be discussed here. | Dr. Dhritiman Maitra, Dept of Surgery, AIIMS, New Delhi | ||
| Introduction to Oral Cancer Screening and its risk factors | 1. Burden of Oral cancer 2. Prevalence, incidence and mortality of oral cancer 3. Causes, signs and symptoms, Risk factors 4. Role of tobacco in oral cancer 5. Common sites of oral cancer |
Dr. Suzanne Nethan, Scientist ‘B’ NICPR, Noida | ||
| Common abnormalities of the oral cavity | 1. Oral Visual examination (including extraoral examination) 2. Oral potentially malignant disorders (OPMDs): old & new nomenclature 3. Common OPMDs & other tobacco-related lesions: Leukoplakia, Erythroplakia, Oral Submucous Fibrosis, Oral Lichen Planus, Lichenoid Lesion, Smoker’s Palate, Tobacco Pouch keratosis 4. Management of OPMDs 5. Oral cancer: clinical features, TNM staging, an overview of management 6. Common diagnostic adjuncts & Biopsy |
Dr. Shalini Gupta, Asst. Prof, CDER, AIIMS, New Delhi | ||
| Tobacco Cessation: Counseling and follow up | 1. Nicotine Replacement Therapy Gums, Patches, Lozenges, Others: Nasal Spray,Inhalers 2. Non-Nicotine therapy Bupropion, Varenicline, Others: Nortriptyline, Clonidine etc. 3. Target population 4. Program design 5. Infrastructural requirements 6. Budget 7. Capacity building 8. Background 9. Importance of m-Health in population-based tobacco cessation 10. Evidence of efficacy of m-Health in tobacco cessation 11. Importance of m-Health in tobacco cessation training |
Dr. Bhavya Bairy, Asst. Prof, NIMHANS, Bengaluru | ||
| Infection Control | 1. Disisinfection of equipment 2. Preparation of disinfectants or 0.5% hypocholorite solution, 3. Sterilization of of cancer screening equipment and disposal of used items |
Dr. Rashmi Asif, Consultant, Ghaziabad, UP | ||
| Breaking the news of screen positivity/ cancer | 1. How to break the news of screen positive news 2. How to calm down the situation in case of adverse raection |
Dr. Chitra Venkateswaran, Foundar and Clinical Director of MEHAC Foundation / Consultant Faculty of Dep. of Oncology and Palliative care, Amrita Institute of Medical Sciences, Kochi, Kerala | ||
| Documenting Cancer Screening Results | 1. The various fields in the proforma for cancer screening 2. Who fills it, how often 3. What is the rationale and purpose behind each field |
Sunita Nadhamuni, Director-Technology, EMC/Dell, Bengaluru |